MDCT Versus MRI Assessment of Tumor Response After Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma

@article{Kloeckner2009MDCTVM,
  title={MDCT Versus MRI Assessment of Tumor Response After Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma},
  author={Roman Kloeckner and Gerd Otto and Stefan Biesterfeld and Katja Oberholzer and Christoph D{\"u}ber and Michael B. Pitton},
  journal={CardioVascular and Interventional Radiology},
  year={2009},
  volume={33},
  pages={532-540}
}
The purpose of this study was to compare the ability of multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) to evaluate treatment results after transarterial chemoembolization (TACE), with a special focus on the influence of Lipiodol on calculation of tumor necrosis according to EASL criteria. A total of 115 nodules in 20 patients (17 males, 3 females; 69.5 ± 9.35 years) with biopsy-proven hepatocellular carcinoma were treated with TACE. Embolization was performed… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 53 CITATIONS, ESTIMATED 61% COVERAGE

MRI assessment of hepatocellular carcinoma after locoregional therapy

VIEW 2 EXCERPTS
CITES BACKGROUND & METHODS

FILTER CITATIONS BY YEAR

2010
2020

CITATION STATISTICS

  • 5 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 27 REFERENCES